Skip to main content
AbbVie Inc.
Healthcare · Drug Manufacturers - General
Made on Jul 31, 2026
Price at call $257.41
6-month call Bear -5.2%
Target by Jan 2027 $244.00
Great value below $210.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change -5.2% to $244.00
Predicted High $259.00 at 1 month
Predicted Low $244.00 at 6 months
Max Drawdown (predicted) -5.2%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Jul 31, 2026 12:49 am
Bear ABBV trends lower to $244.00 (-5.2% from $257.41) by Jan 2027. ride-then-fade
ThesisABBV trades well above composite fair value near $158 but momentum, dividend-king sentiment, and low beta keep it buoyant near-term. Expect modest drift lower over 6 months as value gravity and lack of earnings catalyst allow gentle mean reversion toward the DCF anchor, not a collapse.
Invalidated ifA break above $275 on positive pipeline news or below $235 on guidance cut would invalidate the gentle-fade path.
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $257.41 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Jul 31, 2026 $257.41 at call The anchor — every point below is measured from this price and date.
2 weeks Aug 14, 2026 $242.84–$271.98 typical range · internal point $258.50 ±5.7% 7/10 Momentum and dividend bid persist short-term
What actually happened: closed $250.82 on Aug 13, 2026 = -2.6% vs the call (predicted +0.4%)  ·  direction HIT (called flat, was flat)  ·  off by 3.0 pp  ·  accuracy 9/10  ·  typical range ±5.7%: inside the band  ·  S&P +4.1% over the same window — beat it
1 month Aug 31, 2026 $236.29–$278.53 typical range · internal point $259.00 ±8.2% 6/10 Low-beta drift, no catalyst either direction
2 months Oct 1, 2026 $255.00 -0.9% 5/10 Mild fade as sentiment premium cools
3 months Oct 31, 2026 $252.00 -2.1% 5/10 Q3 print risk, valuation gravity begins
4 months Dec 1, 2026 $248.00 -3.7% 4/10 Drift toward DCF anchor accelerates
5 months Dec 31, 2026 $246.00 -4.4% 4/10 Year-end positioning, tax considerations
6 months Jan 31, 2027 $244.00 -5.2% 4/10 Value convergence continues toward $240 zone

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $248.28 (-3.5%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

0 blocking · 0 degraded · 1 note — follow the chain top-down (cause → effect).
  • Note
    EPV de-weighted — growth IS the value proposition for this type of company
    upstream:classification

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$257.41
Composite fair value$158.15
Signal-adjusted fair value$159.15
DCF fair value$239.37
Anchored-PE fair value$53.91
Buy-below (value lens)$210.00
Value net score-71
Value confidence7 / 10
Quality net score+23
Memo confidence7 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 26.7%  3m 28.4%  6m 27.4%  
Daily σ (realism noise)1.8%
Beta vs S&P 500 1m -0.81  3m -0.55  5m -0.05  
Trailing 6-month return17.7%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Jul 31, 2026 freshest ABBV-20260731-001023-2a47
ext-forensic-memo Jul 31, 2026 freshest ext-ABBV-20260731-003545-88c3
ext-lens-quality Jul 31, 2026 freshest ext-ABBV-20260731-003545-88c3
ext-lens-sentiment Jul 31, 2026 freshest ext-ABBV-20260731-003545-88c3
ext-lens-value Jul 31, 2026 freshest ext-ABBV-20260731-003545-88c3
scenario-valuation Jul 31, 2026 freshest ABBV-20260731-001023-2a47
valuation-synthesis Jul 31, 2026 freshest ABBV-20260731-001023-2a47

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Jul 31, 2026 v0.6.0 Bear $257.41 $244.00 -5.2% Jan 2027 viewing
Jun 24, 2026 v0.3.0 Neutral $234.76 $229.92 -2.1% Dec 2026 view

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.